Literature DB >> 17697226

Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.

D Atkinson1, A Dunne, M Parker.   

Abstract

Methadone is known to prolong the QT interval and precipitate torsades de pointes. A 54-year-old prescription methadone user with hypokalaemia was referred to Critical Care with acute confusion and respiratory distress. Alcohol withdrawal was the presumed precipitant. The real precipitant only became evident on analysis of a 24-h ECG (Holter monitor) attached to the patient at the time. The patient had suffered prolonged (10 min) ventricular arrhythmias including torsades de pointes and self-terminating ventricular fibrillation. The patient made a full recovery. Risk factors for acquired long QT syndrome and the treatment of torsades de pointes are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697226     DOI: 10.1111/j.1365-2044.2007.05129.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.

Authors:  John F Carlquist; David E Moody; Stacey Knight; Eric G Johnson; Wenfang B Fang; John A Huntinghouse; Jeffrey S Rollo; Lynn R Webster; Jeffrey L Anderson
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

Review 2.  Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors:  Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal:  J Anesth       Date:  2017-02-22       Impact factor: 2.078

Review 3.  Methadone: applications in pediatric anesthesiology and critical care medicine.

Authors:  Joseph D Tobias
Journal:  J Anesth       Date:  2021-01-12       Impact factor: 2.078

4.  Torsades de pointes associated with methadone and voriconazole.

Authors:  Jennifer A Reinhold; Cynthia A Sanoski; Andrea M Russo; Joshua M Cooper; Sarah A Spinler
Journal:  BMJ Case Rep       Date:  2009-12-22

5.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

6.  Methadone induced torsades de pointes and ventricular fibrillation: A case review.

Authors:  Somayeh Khalesi; Hassan Shemirani; Faezeh Dehghani-Tafti
Journal:  ARYA Atheroscler       Date:  2014-11

Review 7.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.